{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e4d28688",
   "metadata": {},
   "outputs": [],
   "source": [
    "#from fastapi import FastAPI, UploadFile, File, Form\n",
    "import os\n",
    "import json\n",
    "import complianceGrader\n",
    "import outputFormating\n",
    "import pandas as pd\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0bb2ae86",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Selected product:  TOTAL30\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#Get marketing material\n",
    "marketing_material = input(\"Enter marketing material: \") \n",
    "\n",
    "# Select product - as you add more products it would be better to start using IDs but we are using names for ease of reading here.\n",
    "product=None\n",
    "while product is None:\n",
    "    product_num=input(\"1: Clareon® Toric Intraocular Lens (IOL) or 2:  PRECISION7® Contact Lenses\")\n",
    "\n",
    "    if product_num==\"1\":\n",
    "        product=\"ClareonPanOptix\"\n",
    "\n",
    "    elif product_num==\"2\":\n",
    "        product=\"TOTAL30\"\n",
    "    else:\n",
    "        print(\"Invalid input, please enter 1 or 2.\")\n",
    "    \n",
    "    print(\"Selected product: \", product)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9120105e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt built:  You are a compliance grader evaluating medical marketing content in the U.S.\n",
      "\n",
      "Your goal is to:\n",
      "1) Reward similarity with approved claims.\n",
      "2) Penalize conflicts with FDA + FTC requirements.\n",
      "3) Return structured JSON referencing policy IDs.\n",
      "\n",
      "---\n",
      "\n",
      "## Marketing Text\n",
      "Helps you see better\n",
      "\n",
      "---\n",
      "\n",
      "## Policy Groups\n",
      "\n",
      "Approved Claims (positive alignment)\n",
      "- (approved:0) TOTAL30® contact lenses that feel like nothing, even at day 30.\n",
      "- (approved:1) The first and only monthly replacement Water Gradient contact lenses.\n",
      "- (approved:2) TOTAL30® contact lenses feature a gradual transition in water content, from 55 % at the core to nearly 100 % water at the outermost surface.\n",
      "- (approved:3) Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.\n",
      "- (approved:4) CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.\n",
      "- (approved:5) Helps resist the adherence of bacteria and lipids for a clean lens.\n",
      "- (approved:6) Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.\n",
      "- (approved:7) Class 1 UV Blocking delivers the highest level of UV protection available in a monthly replacement lens.\n",
      "- (approved:8) The first and only monthly replacement Water Gradient toric contact lenses.\n",
      "- (approved:9) TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day 30.\n",
      "\n",
      "\n",
      "FDA Policies\n",
      "- (fda:0) 21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.\n",
      "- (fda:1) 21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.\n",
      "- (fda:2) 21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.\n",
      "- (fda:3) 21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.\n",
      "- (fda:4) 21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.\n",
      "- (fda:5) 21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.\n",
      "- (fda:6) 21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.\n",
      "- (fda:7) 21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.\n",
      "- (fda:8) 21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).\n",
      "- (fda:9) 21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.\n",
      "- (fda:10) 21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.\n",
      "- (fda:11) 21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.\n",
      "- (fda:12) 21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.\n",
      "- (fda:13) 21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.\n",
      "- (fda:14) FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.\n",
      "- (fda:15) 21 CFR § 807.81: When a premarket notification submission is required.\n",
      "- (fda:16) 21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.\n",
      "- (fda:17) 21 CFR § 807.92: Content and format of a 510(k) summary.\n",
      "- (fda:18) 21 CFR § 807.97: Misbranding by reference to premarket notification.\n",
      "- (fda:19) 21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.\n",
      "- (fda:20) 21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.\n",
      "- (fda:21) 21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.\n",
      "- (fda:22) 21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.\n",
      "- (fda:23) 21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.\n",
      "\n",
      "\n",
      "FTC Policies\n",
      "- (ftc:0) § 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.\n",
      "- (ftc:1) § 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.\n",
      "- (ftc:2) § 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.\n",
      "- (ftc:3) § 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.\n",
      "- (ftc:4) § 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.\n",
      "- (ftc:5) § 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.\n",
      "- (ftc:6) § 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.\n",
      "- (ftc:7) § 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.\n",
      "- (ftc:8) § 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.\n",
      "- (ftc:9) § 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.\n",
      "- (ftc:10) § 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.\n",
      "- (ftc:11) § 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.\n",
      "- (ftc:12) § 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.\n",
      "- (ftc:13) § 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.\n",
      "- (ftc:14) § 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.\n",
      "- (ftc:15) § 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.\n",
      "- (ftc:16) § 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.\n",
      "- (ftc:17) § 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.\n",
      "- (ftc:18) § 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.\n",
      "- (ftc:19) § 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.\n",
      "- (ftc:20) § 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.\n",
      "- (ftc:21) § 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.\n",
      "- (ftc:22) § 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.\n",
      "- (ftc:23) § 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.\n",
      "- (ftc:24) 15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.\n",
      "- (ftc:25) 15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.\n",
      "- (ftc:26) 15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.\n",
      "- (ftc:27) 15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.\n",
      "- (ftc:28) 15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.\n",
      "- (ftc:29) 15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.\n",
      "\n",
      "\n",
      "---\n",
      "\n",
      "## Strictness Level\n",
      "Strictness = 5   # 1–10\n",
      "\n",
      "Interpretation:\n",
      "- Strictness 1–3 (lenient): Only clear conflicts should significantly reduce scores. Unsubstantiated or vague claims should receive moderate-to-high grades.\n",
      "- Strictness 4–7 (standard): Use scoring rules as written.\n",
      "- Strictness 8–10 (strict): Be conservative. Require strong evidence for high scores. Penalize weak similarity or even minor risks more heavily.\n",
      "\n",
      "Higher strictness → lower grades for borderline similarity or mild compliance concerns.\n",
      "Lower strictness → higher grades unless clear conflict exists.\n",
      "\n",
      "## Scoring Rules\n",
      "\n",
      "### Approved Claims\n",
      "Evaluate how similar the marketing text is to each approved claim.\n",
      "- Very similar wording → 85–100\n",
      "- Same meaning (rephrased) → 70–85\n",
      "- Partial alignment → 50–70\n",
      "- Unrelated or no alignment → 0–50\n",
      "\n",
      "\n",
      "### FDA / FTC Policies\n",
      "These reflect regulatory requirements.\n",
      "\n",
      "- Fully compliant or unrelated → 80–100\n",
      "- Minor risk or unclear compliance → 60–80\n",
      "- Clear conflict, violation, or misleading claim → 0–60\n",
      "\n",
      "\n",
      "---\n",
      "\n",
      "## Output Rules\n",
      "- You must evaluate EVERY policy in ALL policy groups (Approved, FDA, FTC). No exceptions.\n",
      "- Produce exactly one evaluation object per policy.\n",
      "- For FDA and FTC policies: if the policy is unrelated, output a high grade (80–100) and the reason \"Unrelated; no conflict.\"\n",
      "- For Approved policies: if unrelated, output a low grade (0–50) and the reason \"Unrelated; no similarity.\"\n",
      "- Include: policy_id, policy, type, grade, reason.\n",
      "- Higher scores = stronger compliance.\n",
      "- Return ONLY JSON in the required format.\n",
      "- Do NOT include any text outside the JSON structure.\n",
      "\n",
      "Return ONLY JSON, no commentary.\n",
      "\n",
      "### Output JSON format\n",
      "{\n",
      "  \"evaluations\": [\n",
      "    {\n",
      "        \"policy_id\": \"<approved:3 | fda:7 | ftc:5>\",\n",
      "        \"policy\": \"<policy text>\",\n",
      "      \"type\": \"<approved | fda | ftc>\",\n",
      "      \"grade\": <0-100>,\n",
      "      \"reason\": \"<brief justification>\"\n",
      "    }\n",
      "  ],\n",
      "  \"overall_summary\": \"<short summary>\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "prompt=complianceGrader.buildPrompt(marketing_material, product)\n",
    "print(\"Prompt built: \", prompt)\n",
    "\n",
    "#Get response from LLM\n",
    "output=complianceGrader.getResponseFromLLM(prompt)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9b1de050",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Output from LLM:  {'evaluations': [{'policy_id': 'approved:0', 'policy': 'TOTAL30® contact lenses that feel like nothing, even at day\\u202f30.', 'type': 'approved', 'grade': 50, 'reason': \"Partial alignment: 'Helps you see better' is related to contact lens benefits but does not address comfort or specific product claims.\"}, {'policy_id': 'approved:1', 'policy': 'The first and only monthly replacement Water Gradient contact lenses.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no similarity to monthly replacement or water gradient technology.'}, {'policy_id': 'approved:2', 'policy': 'TOTAL30® contact lenses feature a gradual transition in water content, from 55\\u202f% at the core to nearly 100\\u202f% water at the outermost surface.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of water content or lens features.'}, {'policy_id': 'approved:3', 'policy': 'Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no reference to Water Gradient Technology or duration.'}, {'policy_id': 'approved:4', 'policy': 'CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of CELLIGENT® Technology.'}, {'policy_id': 'approved:5', 'policy': 'Helps resist the adherence of bacteria and lipids for a clean lens.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of bacterial or lipid resistance.'}, {'policy_id': 'approved:6', 'policy': 'Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of softness or lubricity benefits.'}, {'policy_id': 'approved:7', 'policy': 'Class\\u202f1\\u202fUV Blocking delivers the highest level of UV protection available in a monthly replacement lens.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of UV blocking or protection.'}, {'policy_id': 'approved:8', 'policy': 'The first and only monthly replacement Water Gradient toric contact lenses.', 'type': 'approved', 'grade': 0, 'reason': 'Unrelated; no mention of toric lenses or monthly replacement.'}, {'policy_id': 'approved:9', 'policy': 'TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day\\u202f30.', 'type': 'approved', 'grade': 50, 'reason': \"Partial alignment: 'Helps you see better' relates to vision correction but lacks specific clinical claims or comfort info.\"}, {'policy_id': 'fda:0', 'policy': '21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no device description or intended use conflict.'}, {'policy_id': 'fda:1', 'policy': '21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no mention of wear classification or duration.'}, {'policy_id': 'fda:2', 'policy': '21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no premarket approval discussion or claim.'}, {'policy_id': 'fda:3', 'policy': '21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no classification issues with marketing text.'}, {'policy_id': 'fda:4', 'policy': '21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no labeling content in marketing text.'}, {'policy_id': 'fda:5', 'policy': '21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no UDI or labeling definitions referenced.'}, {'policy_id': 'fda:6', 'policy': '21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; marketing text does not provide directions for use.'}, {'policy_id': 'fda:7', 'policy': '21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no label prominence or conspicuousness issues.'}, {'policy_id': 'fda:8', 'policy': '21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no date labeling included.'}, {'policy_id': 'fda:9', 'policy': '21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; marketing text is not a labeling or packaging chart.'}, {'policy_id': 'fda:10', 'policy': '21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; marketing text does not discuss labeling or UDI.'}, {'policy_id': 'fda:11', 'policy': '21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no mention of UDI marking or device reuse.'}, {'policy_id': 'fda:12', 'policy': '21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; marketing text unrelated to UDI system.'}, {'policy_id': 'fda:13', 'policy': '21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no mention of GUDID or data submission.'}, {'policy_id': 'fda:14', 'policy': 'FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no discussion of compliance or labeling dates.'}, {'policy_id': 'fda:15', 'policy': '21 CFR § 807.81: When a premarket notification submission is required.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no premarket notification discussion.'}, {'policy_id': 'fda:16', 'policy': '21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; marketing text does not cover 510(k) content.'}, {'policy_id': 'fda:17', 'policy': '21 CFR § 807.92: Content and format of a 510(k) summary.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no 510(k) summary content.'}, {'policy_id': 'fda:18', 'policy': '21 CFR § 807.97: Misbranding by reference to premarket notification.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no misbranding or reference issues.'}, {'policy_id': 'fda:19', 'policy': '21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no adverse event reporting context.'}, {'policy_id': 'fda:20', 'policy': '21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no mention of recordkeeping or MDR.'}, {'policy_id': 'fda:21', 'policy': '21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no device corrections or removals referenced.'}, {'policy_id': 'fda:22', 'policy': '21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no ophthalmic solutions or sterility claims.'}, {'policy_id': 'fda:23', 'policy': '21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.', 'type': 'fda', 'grade': 80, 'reason': 'Unrelated; no packaging or tamper-evident claims.'}, {'policy_id': 'ftc:0', 'policy': '§ 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription or sales conflicts.'}, {'policy_id': 'ftc:1', 'policy': '§ 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no business hours or communication issues.'}, {'policy_id': 'ftc:2', 'policy': '§ 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; marketing text does not mention prescriptions.'}, {'policy_id': 'ftc:3', 'policy': '§ 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no fitting or prescription issuance claims.'}, {'policy_id': 'ftc:4', 'policy': '§ 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription verification mention.'}, {'policy_id': 'ftc:5', 'policy': '§ 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no sales or waiver conditions mentioned.'}, {'policy_id': 'ftc:6', 'policy': '§ 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no confirmation or receipt evidence claims.'}, {'policy_id': 'ftc:7', 'policy': '§ 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no record retention mentioned.'}, {'policy_id': 'ftc:8', 'policy': '§ 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no payment or prescription release issues stated.'}, {'policy_id': 'ftc:9', 'policy': '§ 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no selling or prescription verification referenced.'}, {'policy_id': 'ftc:10', 'policy': '§ 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription verification communication.'}, {'policy_id': 'ftc:11', 'policy': '§ 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no passive verification discussion.'}, {'policy_id': 'ftc:12', 'policy': '§ 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no automated verification mentioned.'}, {'policy_id': 'ftc:13', 'policy': '§ 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription accuracy or filling claims.'}, {'policy_id': 'ftc:14', 'policy': '§ 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription expiration expressed.'}, {'policy_id': 'ftc:15', 'policy': '§ 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; marketing text does not imply prescription not needed.'}, {'policy_id': 'ftc:16', 'policy': '§ 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no waiver or release requirement mentioned.'}, {'policy_id': 'ftc:17', 'policy': '§ 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no unfair or deceptive practice alleged.'}, {'policy_id': 'ftc:18', 'policy': '§ 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no endorsements or opinions used.'}, {'policy_id': 'ftc:19', 'policy': '§ 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no endorsement or performance claims made.'}, {'policy_id': 'ftc:20', 'policy': '§ 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no expert endorsement present.'}, {'policy_id': 'ftc:21', 'policy': '§ 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no organizational endorsement.'}, {'policy_id': 'ftc:22', 'policy': '§ 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no endorsement or disclosure provided.'}, {'policy_id': 'ftc:23', 'policy': '§ 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no endorsements or targeting children.'}, {'policy_id': 'ftc:24', 'policy': '15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; marketing text does not contain unfair or deceptive practices.'}, {'policy_id': 'ftc:25', 'policy': '15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.', 'type': 'ftc', 'grade': 75, 'reason': \"Minor risk: Claim 'Helps you see better' is vague and lacks specificity or substantiation provided here.\"}, {'policy_id': 'ftc:26', 'policy': '15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.', 'type': 'ftc', 'grade': 70, 'reason': 'Minor risk: The claim is broadly stated without qualification or specific substantiation disclosed.'}, {'policy_id': 'ftc:27', 'policy': '15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription provision claim.'}, {'policy_id': 'ftc:28', 'policy': '15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no prescription verification context.'}, {'policy_id': 'ftc:29', 'policy': '15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 80, 'reason': 'Unrelated; no statement suggesting no prescription needed.'}], 'overall_summary': \"The marketing text 'Helps you see better' is a broad, non-specific vision claim that partially aligns with some approved claims related to vision improvement but lacks detailed substantiation. No FDA or FTC conflicts found, though FTC advertising standards impose a minor risk caution for lack of clarity or evidence.\"}\n"
     ]
    }
   ],
   "source": [
    "print(\"Output from LLM: \", output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "183a98cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "df = pd.DataFrame(output['evaluations'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "e20ae91d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "policy_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "policy",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "grade",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "reason",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "35e32492-e591-4cd1-8bc9-cb09ab783e85",
       "rows": [
        [
         "0",
         "approved:0",
         "TOTAL30® contact lenses that feel like nothing, even at day 30.",
         "approved",
         "50",
         "Partial alignment: 'Helps you see better' is related to contact lens benefits but does not address comfort or specific product claims."
        ],
        [
         "1",
         "approved:1",
         "The first and only monthly replacement Water Gradient contact lenses.",
         "approved",
         "0",
         "Unrelated; no similarity to monthly replacement or water gradient technology."
        ],
        [
         "2",
         "approved:2",
         "TOTAL30® contact lenses feature a gradual transition in water content, from 55 % at the core to nearly 100 % water at the outermost surface.",
         "approved",
         "0",
         "Unrelated; no mention of water content or lens features."
        ],
        [
         "3",
         "approved:3",
         "Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.",
         "approved",
         "0",
         "Unrelated; no reference to Water Gradient Technology or duration."
        ],
        [
         "4",
         "approved:4",
         "CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.",
         "approved",
         "0",
         "Unrelated; no mention of CELLIGENT® Technology."
        ],
        [
         "5",
         "approved:5",
         "Helps resist the adherence of bacteria and lipids for a clean lens.",
         "approved",
         "0",
         "Unrelated; no mention of bacterial or lipid resistance."
        ],
        [
         "6",
         "approved:6",
         "Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.",
         "approved",
         "0",
         "Unrelated; no mention of softness or lubricity benefits."
        ],
        [
         "7",
         "approved:7",
         "Class 1 UV Blocking delivers the highest level of UV protection available in a monthly replacement lens.",
         "approved",
         "0",
         "Unrelated; no mention of UV blocking or protection."
        ],
        [
         "8",
         "approved:8",
         "The first and only monthly replacement Water Gradient toric contact lenses.",
         "approved",
         "0",
         "Unrelated; no mention of toric lenses or monthly replacement."
        ],
        [
         "9",
         "approved:9",
         "TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day 30.",
         "approved",
         "50",
         "Partial alignment: 'Helps you see better' relates to vision correction but lacks specific clinical claims or comfort info."
        ],
        [
         "10",
         "fda:0",
         "21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.",
         "fda",
         "80",
         "Unrelated; no device description or intended use conflict."
        ],
        [
         "11",
         "fda:1",
         "21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.",
         "fda",
         "80",
         "Unrelated; no mention of wear classification or duration."
        ],
        [
         "12",
         "fda:2",
         "21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.",
         "fda",
         "80",
         "Unrelated; no premarket approval discussion or claim."
        ],
        [
         "13",
         "fda:3",
         "21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.",
         "fda",
         "80",
         "Unrelated; no classification issues with marketing text."
        ],
        [
         "14",
         "fda:4",
         "21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.",
         "fda",
         "80",
         "Unrelated; no labeling content in marketing text."
        ],
        [
         "15",
         "fda:5",
         "21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.",
         "fda",
         "80",
         "Unrelated; no UDI or labeling definitions referenced."
        ],
        [
         "16",
         "fda:6",
         "21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.",
         "fda",
         "80",
         "Unrelated; marketing text does not provide directions for use."
        ],
        [
         "17",
         "fda:7",
         "21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.",
         "fda",
         "80",
         "Unrelated; no label prominence or conspicuousness issues."
        ],
        [
         "18",
         "fda:8",
         "21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).",
         "fda",
         "80",
         "Unrelated; no date labeling included."
        ],
        [
         "19",
         "fda:9",
         "21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.",
         "fda",
         "80",
         "Unrelated; marketing text is not a labeling or packaging chart."
        ],
        [
         "20",
         "fda:10",
         "21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.",
         "fda",
         "80",
         "Unrelated; marketing text does not discuss labeling or UDI."
        ],
        [
         "21",
         "fda:11",
         "21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.",
         "fda",
         "80",
         "Unrelated; no mention of UDI marking or device reuse."
        ],
        [
         "22",
         "fda:12",
         "21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.",
         "fda",
         "80",
         "Unrelated; marketing text unrelated to UDI system."
        ],
        [
         "23",
         "fda:13",
         "21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.",
         "fda",
         "80",
         "Unrelated; no mention of GUDID or data submission."
        ],
        [
         "24",
         "fda:14",
         "FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.",
         "fda",
         "80",
         "Unrelated; no discussion of compliance or labeling dates."
        ],
        [
         "25",
         "fda:15",
         "21 CFR § 807.81: When a premarket notification submission is required.",
         "fda",
         "80",
         "Unrelated; no premarket notification discussion."
        ],
        [
         "26",
         "fda:16",
         "21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.",
         "fda",
         "80",
         "Unrelated; marketing text does not cover 510(k) content."
        ],
        [
         "27",
         "fda:17",
         "21 CFR § 807.92: Content and format of a 510(k) summary.",
         "fda",
         "80",
         "Unrelated; no 510(k) summary content."
        ],
        [
         "28",
         "fda:18",
         "21 CFR § 807.97: Misbranding by reference to premarket notification.",
         "fda",
         "80",
         "Unrelated; no misbranding or reference issues."
        ],
        [
         "29",
         "fda:19",
         "21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.",
         "fda",
         "80",
         "Unrelated; no adverse event reporting context."
        ],
        [
         "30",
         "fda:20",
         "21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.",
         "fda",
         "80",
         "Unrelated; no mention of recordkeeping or MDR."
        ],
        [
         "31",
         "fda:21",
         "21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.",
         "fda",
         "80",
         "Unrelated; no device corrections or removals referenced."
        ],
        [
         "32",
         "fda:22",
         "21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.",
         "fda",
         "80",
         "Unrelated; no ophthalmic solutions or sterility claims."
        ],
        [
         "33",
         "fda:23",
         "21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.",
         "fda",
         "80",
         "Unrelated; no packaging or tamper-evident claims."
        ],
        [
         "34",
         "ftc:0",
         "§ 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.",
         "ftc",
         "80",
         "Unrelated; no prescription or sales conflicts."
        ],
        [
         "35",
         "ftc:1",
         "§ 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.",
         "ftc",
         "80",
         "Unrelated; no business hours or communication issues."
        ],
        [
         "36",
         "ftc:2",
         "§ 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.",
         "ftc",
         "80",
         "Unrelated; marketing text does not mention prescriptions."
        ],
        [
         "37",
         "ftc:3",
         "§ 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.",
         "ftc",
         "80",
         "Unrelated; no fitting or prescription issuance claims."
        ],
        [
         "38",
         "ftc:4",
         "§ 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.",
         "ftc",
         "80",
         "Unrelated; no prescription verification mention."
        ],
        [
         "39",
         "ftc:5",
         "§ 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.",
         "ftc",
         "80",
         "Unrelated; no sales or waiver conditions mentioned."
        ],
        [
         "40",
         "ftc:6",
         "§ 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.",
         "ftc",
         "80",
         "Unrelated; no confirmation or receipt evidence claims."
        ],
        [
         "41",
         "ftc:7",
         "§ 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.",
         "ftc",
         "80",
         "Unrelated; no record retention mentioned."
        ],
        [
         "42",
         "ftc:8",
         "§ 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.",
         "ftc",
         "80",
         "Unrelated; no payment or prescription release issues stated."
        ],
        [
         "43",
         "ftc:9",
         "§ 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.",
         "ftc",
         "80",
         "Unrelated; no selling or prescription verification referenced."
        ],
        [
         "44",
         "ftc:10",
         "§ 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.",
         "ftc",
         "80",
         "Unrelated; no prescription verification communication."
        ],
        [
         "45",
         "ftc:11",
         "§ 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.",
         "ftc",
         "80",
         "Unrelated; no passive verification discussion."
        ],
        [
         "46",
         "ftc:12",
         "§ 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.",
         "ftc",
         "80",
         "Unrelated; no automated verification mentioned."
        ],
        [
         "47",
         "ftc:13",
         "§ 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.",
         "ftc",
         "80",
         "Unrelated; no prescription accuracy or filling claims."
        ],
        [
         "48",
         "ftc:14",
         "§ 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.",
         "ftc",
         "80",
         "Unrelated; no prescription expiration expressed."
        ],
        [
         "49",
         "ftc:15",
         "§ 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.",
         "ftc",
         "80",
         "Unrelated; marketing text does not imply prescription not needed."
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 60
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>policy_id</th>\n",
       "      <th>policy</th>\n",
       "      <th>type</th>\n",
       "      <th>grade</th>\n",
       "      <th>reason</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>approved:0</td>\n",
       "      <td>TOTAL30® contact lenses that feel like nothing...</td>\n",
       "      <td>approved</td>\n",
       "      <td>50</td>\n",
       "      <td>Partial alignment: 'Helps you see better' is r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>approved:1</td>\n",
       "      <td>The first and only monthly replacement Water G...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no similarity to monthly replacemen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>approved:2</td>\n",
       "      <td>TOTAL30® contact lenses feature a gradual tran...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of water content or lens...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>approved:3</td>\n",
       "      <td>Water Gradient Technology in TOTAL30 contact l...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no reference to Water Gradient Tech...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>approved:4</td>\n",
       "      <td>CELLIGENT® Technology creates a dynamic lens s...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of CELLIGENT® Technology.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>approved:5</td>\n",
       "      <td>Helps resist the adherence of bacteria and lip...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of bacterial or lipid re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>approved:6</td>\n",
       "      <td>Water Gradient delivers superior softness and ...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of softness or lubricity...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>approved:7</td>\n",
       "      <td>Class 1 UV Blocking delivers the highest level...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of UV blocking or protec...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>approved:8</td>\n",
       "      <td>The first and only monthly replacement Water G...</td>\n",
       "      <td>approved</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated; no mention of toric lenses or month...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>approved:9</td>\n",
       "      <td>TOTAL30 delivers the only Water Gradient, reus...</td>\n",
       "      <td>approved</td>\n",
       "      <td>50</td>\n",
       "      <td>Partial alignment: 'Helps you see better' rela...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>fda:0</td>\n",
       "      <td>21 CFR § 886.5925(a): A soft (hydrophilic) con...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no device description or intended u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>fda:1</td>\n",
       "      <td>21 CFR § 886.5925(b)(1)-(2): Classification—Cl...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no mention of wear classification o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>fda:2</td>\n",
       "      <td>21 CFR § 886.5925(c): As of May 28, 1976, a PM...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no premarket approval discussion or...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>fda:3</td>\n",
       "      <td>21 CFR § 886.1(a): This part sets forth the cl...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no classification issues with marke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>fda:4</td>\n",
       "      <td>21 CFR § 801.1(a): The label of a device in pa...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no labeling content in marketing text.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>fda:5</td>\n",
       "      <td>21 CFR § 801.3: Definitions—includes, among ot...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no UDI or labeling definitions refe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>fda:6</td>\n",
       "      <td>21 CFR § 801.5: Adequate directions for use me...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not provide dir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>fda:7</td>\n",
       "      <td>21 CFR § 801.15(a): Required label information...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no label prominence or conspicuousn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>fda:8</td>\n",
       "      <td>21 CFR § 801.18(a): Dates on device labels mus...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no date labeling included.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>fda:9</td>\n",
       "      <td>21 CFR § 801.109(c)-(d): Prescription devices—...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text is not a labeling or...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>fda:10</td>\n",
       "      <td>21 CFR § 801.20(a)(1)-(2): The label of every ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not discuss lab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>fda:11</td>\n",
       "      <td>21 CFR § 801.45(a): A device required to bear ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no mention of UDI marking or device...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>fda:12</td>\n",
       "      <td>21 CFR Part 830 (e.g., § 830.3): Establishes U...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text unrelated to UDI sys...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>fda:13</td>\n",
       "      <td>21 CFR § 830.310: GUDID data submission—labele...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no mention of GUDID or data submiss...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>fda:14</td>\n",
       "      <td>FDA UDI Compliance Dates: Labels and packages ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no discussion of compliance or labe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>fda:15</td>\n",
       "      <td>21 CFR § 807.81: When a premarket notification...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no premarket notification discussion.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>fda:16</td>\n",
       "      <td>21 CFR § 807.87: Information required in a pre...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not cover 510(k...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>fda:17</td>\n",
       "      <td>21 CFR § 807.92: Content and format of a 510(k...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no 510(k) summary content.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>fda:18</td>\n",
       "      <td>21 CFR § 807.97: Misbranding by reference to p...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no misbranding or reference issues.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>fda:19</td>\n",
       "      <td>21 CFR § 803.50(a): Manufacturer reporting—mus...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no adverse event reporting context.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>fda:20</td>\n",
       "      <td>21 CFR § 803.18(a): User facilities, importers...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no mention of recordkeeping or MDR.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>fda:21</td>\n",
       "      <td>21 CFR Part 806 (§ 806.1): Manufacturers and i...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no device corrections or removals r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>fda:22</td>\n",
       "      <td>21 CFR § 800.10(a)(1): All preparations intend...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no ophthalmic solutions or sterilit...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>fda:23</td>\n",
       "      <td>21 CFR § 800.12: Contact lens solutions and ta...</td>\n",
       "      <td>fda</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no packaging or tamper-evident claims.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>ftc:0</td>\n",
       "      <td>§ 315.1: This part, which shall be called the ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no prescription or sales conflicts.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>ftc:1</td>\n",
       "      <td>§ 315.2: “Business hours” means the prescriber...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no business hours or communication ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>ftc:2</td>\n",
       "      <td>§ 315.2: “Contact lens prescription” means a p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not mention pre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>ftc:3</td>\n",
       "      <td>§ 315.3(a)(1): When a prescriber completes a c...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no fitting or prescription issuance...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>ftc:4</td>\n",
       "      <td>§ 315.3(a)(2)-(3): The prescriber shall, as di...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no prescription verification mention.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>ftc:5</td>\n",
       "      <td>§ 315.3(b): A prescriber may not require the p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no sales or waiver conditions menti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>ftc:6</td>\n",
       "      <td>§ 315.3(c)(1): Upon completion of a fitting, t...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no confirmation or receipt evidence...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>ftc:7</td>\n",
       "      <td>§ 315.3(c)(3): A prescriber must maintain for ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no record retention mentioned.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>ftc:8</td>\n",
       "      <td>§ 315.4: A prescriber may require payment befo...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no payment or prescription release ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>ftc:9</td>\n",
       "      <td>§ 315.5(a): A seller may sell contact lenses o...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no selling or prescription verifica...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>ftc:10</td>\n",
       "      <td>§ 315.5(b): For verification, a seller shall p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no prescription verification commun...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>ftc:11</td>\n",
       "      <td>§ 315.5(c)(3): Passive verification—prescripti...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no passive verification discussion.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>ftc:12</td>\n",
       "      <td>§ 315.5(d): Automated telephone verification m...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no automated verification mentioned.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>ftc:13</td>\n",
       "      <td>§ 315.5(e)-(f): If informed a prescription is ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no prescription accuracy or filling...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>ftc:14</td>\n",
       "      <td>§ 315.6(a): A contact lens prescription shall ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no prescription expiration expressed.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>ftc:15</td>\n",
       "      <td>§ 315.7: No person may represent, by advertise...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not imply presc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>ftc:16</td>\n",
       "      <td>§ 315.8: A prescriber may not require a patien...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no waiver or release requirement me...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>ftc:17</td>\n",
       "      <td>§ 315.9: Any violation of this Rule shall be t...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no unfair or deceptive practice all...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>ftc:18</td>\n",
       "      <td>§ 255.1(a): Endorsements must reflect the hone...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no endorsements or opinions used.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>ftc:19</td>\n",
       "      <td>§ 255.2(b): If the advertiser does not have su...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no endorsement or performance claim...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>ftc:20</td>\n",
       "      <td>§ 255.3(a): Expert endorsements must be suppor...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no expert endorsement present.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>ftc:21</td>\n",
       "      <td>§ 255.4: Organizational endorsements shall be ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no organizational endorsement.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>ftc:22</td>\n",
       "      <td>§ 255.5: When there exists a connection betwee...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no endorsement or disclosure provided.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>ftc:23</td>\n",
       "      <td>§ 255.6: Endorsements directed to children are...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; no endorsements or targeting children.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>ftc:24</td>\n",
       "      <td>15 U.S.C. § 45(a)(1): Unfair methods of compet...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>80</td>\n",
       "      <td>Unrelated; marketing text does not contain unf...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>ftc:25</td>\n",
       "      <td>15 U.S.C. § 52(a): It shall be unlawful for an...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>75</td>\n",
       "      <td>Minor risk: Claim 'Helps you see better' is va...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     policy_id                                             policy      type  \\\n",
       "0   approved:0  TOTAL30® contact lenses that feel like nothing...  approved   \n",
       "1   approved:1  The first and only monthly replacement Water G...  approved   \n",
       "2   approved:2  TOTAL30® contact lenses feature a gradual tran...  approved   \n",
       "3   approved:3  Water Gradient Technology in TOTAL30 contact l...  approved   \n",
       "4   approved:4  CELLIGENT® Technology creates a dynamic lens s...  approved   \n",
       "5   approved:5  Helps resist the adherence of bacteria and lip...  approved   \n",
       "6   approved:6  Water Gradient delivers superior softness and ...  approved   \n",
       "7   approved:7  Class 1 UV Blocking delivers the highest level...  approved   \n",
       "8   approved:8  The first and only monthly replacement Water G...  approved   \n",
       "9   approved:9  TOTAL30 delivers the only Water Gradient, reus...  approved   \n",
       "10       fda:0  21 CFR § 886.5925(a): A soft (hydrophilic) con...       fda   \n",
       "11       fda:1  21 CFR § 886.5925(b)(1)-(2): Classification—Cl...       fda   \n",
       "12       fda:2  21 CFR § 886.5925(c): As of May 28, 1976, a PM...       fda   \n",
       "13       fda:3  21 CFR § 886.1(a): This part sets forth the cl...       fda   \n",
       "14       fda:4  21 CFR § 801.1(a): The label of a device in pa...       fda   \n",
       "15       fda:5  21 CFR § 801.3: Definitions—includes, among ot...       fda   \n",
       "16       fda:6  21 CFR § 801.5: Adequate directions for use me...       fda   \n",
       "17       fda:7  21 CFR § 801.15(a): Required label information...       fda   \n",
       "18       fda:8  21 CFR § 801.18(a): Dates on device labels mus...       fda   \n",
       "19       fda:9  21 CFR § 801.109(c)-(d): Prescription devices—...       fda   \n",
       "20      fda:10  21 CFR § 801.20(a)(1)-(2): The label of every ...       fda   \n",
       "21      fda:11  21 CFR § 801.45(a): A device required to bear ...       fda   \n",
       "22      fda:12  21 CFR Part 830 (e.g., § 830.3): Establishes U...       fda   \n",
       "23      fda:13  21 CFR § 830.310: GUDID data submission—labele...       fda   \n",
       "24      fda:14  FDA UDI Compliance Dates: Labels and packages ...       fda   \n",
       "25      fda:15  21 CFR § 807.81: When a premarket notification...       fda   \n",
       "26      fda:16  21 CFR § 807.87: Information required in a pre...       fda   \n",
       "27      fda:17  21 CFR § 807.92: Content and format of a 510(k...       fda   \n",
       "28      fda:18  21 CFR § 807.97: Misbranding by reference to p...       fda   \n",
       "29      fda:19  21 CFR § 803.50(a): Manufacturer reporting—mus...       fda   \n",
       "30      fda:20  21 CFR § 803.18(a): User facilities, importers...       fda   \n",
       "31      fda:21  21 CFR Part 806 (§ 806.1): Manufacturers and i...       fda   \n",
       "32      fda:22  21 CFR § 800.10(a)(1): All preparations intend...       fda   \n",
       "33      fda:23  21 CFR § 800.12: Contact lens solutions and ta...       fda   \n",
       "34       ftc:0  § 315.1: This part, which shall be called the ...       ftc   \n",
       "35       ftc:1  § 315.2: “Business hours” means the prescriber...       ftc   \n",
       "36       ftc:2  § 315.2: “Contact lens prescription” means a p...       ftc   \n",
       "37       ftc:3  § 315.3(a)(1): When a prescriber completes a c...       ftc   \n",
       "38       ftc:4  § 315.3(a)(2)-(3): The prescriber shall, as di...       ftc   \n",
       "39       ftc:5  § 315.3(b): A prescriber may not require the p...       ftc   \n",
       "40       ftc:6  § 315.3(c)(1): Upon completion of a fitting, t...       ftc   \n",
       "41       ftc:7  § 315.3(c)(3): A prescriber must maintain for ...       ftc   \n",
       "42       ftc:8  § 315.4: A prescriber may require payment befo...       ftc   \n",
       "43       ftc:9  § 315.5(a): A seller may sell contact lenses o...       ftc   \n",
       "44      ftc:10  § 315.5(b): For verification, a seller shall p...       ftc   \n",
       "45      ftc:11  § 315.5(c)(3): Passive verification—prescripti...       ftc   \n",
       "46      ftc:12  § 315.5(d): Automated telephone verification m...       ftc   \n",
       "47      ftc:13  § 315.5(e)-(f): If informed a prescription is ...       ftc   \n",
       "48      ftc:14  § 315.6(a): A contact lens prescription shall ...       ftc   \n",
       "49      ftc:15  § 315.7: No person may represent, by advertise...       ftc   \n",
       "50      ftc:16  § 315.8: A prescriber may not require a patien...       ftc   \n",
       "51      ftc:17  § 315.9: Any violation of this Rule shall be t...       ftc   \n",
       "52      ftc:18  § 255.1(a): Endorsements must reflect the hone...       ftc   \n",
       "53      ftc:19  § 255.2(b): If the advertiser does not have su...       ftc   \n",
       "54      ftc:20  § 255.3(a): Expert endorsements must be suppor...       ftc   \n",
       "55      ftc:21  § 255.4: Organizational endorsements shall be ...       ftc   \n",
       "56      ftc:22  § 255.5: When there exists a connection betwee...       ftc   \n",
       "57      ftc:23  § 255.6: Endorsements directed to children are...       ftc   \n",
       "58      ftc:24  15 U.S.C. § 45(a)(1): Unfair methods of compet...       ftc   \n",
       "59      ftc:25  15 U.S.C. § 52(a): It shall be unlawful for an...       ftc   \n",
       "\n",
       "    grade                                             reason  \n",
       "0      50  Partial alignment: 'Helps you see better' is r...  \n",
       "1       0  Unrelated; no similarity to monthly replacemen...  \n",
       "2       0  Unrelated; no mention of water content or lens...  \n",
       "3       0  Unrelated; no reference to Water Gradient Tech...  \n",
       "4       0    Unrelated; no mention of CELLIGENT® Technology.  \n",
       "5       0  Unrelated; no mention of bacterial or lipid re...  \n",
       "6       0  Unrelated; no mention of softness or lubricity...  \n",
       "7       0  Unrelated; no mention of UV blocking or protec...  \n",
       "8       0  Unrelated; no mention of toric lenses or month...  \n",
       "9      50  Partial alignment: 'Helps you see better' rela...  \n",
       "10     80  Unrelated; no device description or intended u...  \n",
       "11     80  Unrelated; no mention of wear classification o...  \n",
       "12     80  Unrelated; no premarket approval discussion or...  \n",
       "13     80  Unrelated; no classification issues with marke...  \n",
       "14     80  Unrelated; no labeling content in marketing text.  \n",
       "15     80  Unrelated; no UDI or labeling definitions refe...  \n",
       "16     80  Unrelated; marketing text does not provide dir...  \n",
       "17     80  Unrelated; no label prominence or conspicuousn...  \n",
       "18     80              Unrelated; no date labeling included.  \n",
       "19     80  Unrelated; marketing text is not a labeling or...  \n",
       "20     80  Unrelated; marketing text does not discuss lab...  \n",
       "21     80  Unrelated; no mention of UDI marking or device...  \n",
       "22     80  Unrelated; marketing text unrelated to UDI sys...  \n",
       "23     80  Unrelated; no mention of GUDID or data submiss...  \n",
       "24     80  Unrelated; no discussion of compliance or labe...  \n",
       "25     80   Unrelated; no premarket notification discussion.  \n",
       "26     80  Unrelated; marketing text does not cover 510(k...  \n",
       "27     80              Unrelated; no 510(k) summary content.  \n",
       "28     80     Unrelated; no misbranding or reference issues.  \n",
       "29     80     Unrelated; no adverse event reporting context.  \n",
       "30     80     Unrelated; no mention of recordkeeping or MDR.  \n",
       "31     80  Unrelated; no device corrections or removals r...  \n",
       "32     80  Unrelated; no ophthalmic solutions or sterilit...  \n",
       "33     80  Unrelated; no packaging or tamper-evident claims.  \n",
       "34     80     Unrelated; no prescription or sales conflicts.  \n",
       "35     80  Unrelated; no business hours or communication ...  \n",
       "36     80  Unrelated; marketing text does not mention pre...  \n",
       "37     80  Unrelated; no fitting or prescription issuance...  \n",
       "38     80   Unrelated; no prescription verification mention.  \n",
       "39     80  Unrelated; no sales or waiver conditions menti...  \n",
       "40     80  Unrelated; no confirmation or receipt evidence...  \n",
       "41     80          Unrelated; no record retention mentioned.  \n",
       "42     80  Unrelated; no payment or prescription release ...  \n",
       "43     80  Unrelated; no selling or prescription verifica...  \n",
       "44     80  Unrelated; no prescription verification commun...  \n",
       "45     80     Unrelated; no passive verification discussion.  \n",
       "46     80    Unrelated; no automated verification mentioned.  \n",
       "47     80  Unrelated; no prescription accuracy or filling...  \n",
       "48     80   Unrelated; no prescription expiration expressed.  \n",
       "49     80  Unrelated; marketing text does not imply presc...  \n",
       "50     80  Unrelated; no waiver or release requirement me...  \n",
       "51     80  Unrelated; no unfair or deceptive practice all...  \n",
       "52     80       Unrelated; no endorsements or opinions used.  \n",
       "53     80  Unrelated; no endorsement or performance claim...  \n",
       "54     80          Unrelated; no expert endorsement present.  \n",
       "55     80          Unrelated; no organizational endorsement.  \n",
       "56     80  Unrelated; no endorsement or disclosure provided.  \n",
       "57     80  Unrelated; no endorsements or targeting children.  \n",
       "58     80  Unrelated; marketing text does not contain unf...  \n",
       "59     75  Minor risk: Claim 'Helps you see better' is va...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(60)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "b019afe6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Approved Score:  50\n",
      "FDA Score:  80.0\n",
      "FTC Score:  79.5\n"
     ]
    }
   ],
   "source": [
    "#get catagory scores\n",
    "approved_scores = df[df['type'] == 'approved']['grade']\n",
    "fda_scores = df[df['type'] == 'fda']['grade']\n",
    "ftc_scores = df[df['type'] == 'ftc']['grade']\n",
    "\n",
    "approved_score = approved_scores.max() if not approved_scores.empty else None\n",
    "\n",
    "def compute_category_score(df, category, threshold=70):\n",
    "    scores = df[df['type'] == category]['grade']\n",
    "\n",
    "    if scores.empty:\n",
    "        return 0\n",
    "    \n",
    "    base = scores.mean()\n",
    "    non_compliant_ratio = (scores < threshold).mean()\n",
    "    penalty = non_compliant_ratio * 100\n",
    "    \n",
    "    final = base - penalty\n",
    "    return max(0, min(100, final))  # clamp\n",
    "\n",
    "fda_score = compute_category_score(df, \"fda\")\n",
    "ftc_score = compute_category_score(df, \"ftc\")\n",
    "\n",
    "print(\"Approved Score: \", approved_score)\n",
    "print(\"FDA Score: \", fda_score)\n",
    "print(\"FTC Score: \", ftc_score)\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
